Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift Revenue
(feeds.content.dowjones.io)
1.
2.
3.
‘The Testaments’ Has Been Renewed for Season 2
(gizmodo.com)
4.
5.
6.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
7.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
9.
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets
(feeds.content.dowjones.io)
10.
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
(feeds.content.dowjones.io)
11.
FDA has approved Yeztugo, a drug that provides protection against HIV infection
(news.ycombinator.com)
12.
The first 100% effective HIV prevention drug is approved and going global
(news.ycombinator.com)
13.
FDA Approves ‘Breakthough’ Drug to Prevent HIV
(gizmodo.com)
Today's top topics:
google
pixel 11
tensor g6
trump administration
pixel watch 5
apple tv
kospi
chatgpt
gemini
promo codes